These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 16780671)
1. [Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial]. Hu HT; Zhang ZX; Yao JL; Yu HZ; Wang YH; Tang HC; Ji CJ; Xu T Zhonghua Nei Ke Za Zhi; 2006 Apr; 45(4):277-80. PubMed ID: 16780671 [TBL] [Abstract][Full Text] [Related]
2. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. Tariot PN; Farlow MR; Grossberg GT; Graham SM; McDonald S; Gergel I; JAMA; 2004 Jan; 291(3):317-24. PubMed ID: 14734594 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990 [TBL] [Abstract][Full Text] [Related]
4. Donepezil and memantine for moderate-to-severe Alzheimer's disease. Howard R; McShane R; Lindesay J; Ritchie C; Baldwin A; Barber R; Burns A; Dening T; Findlay D; Holmes C; Hughes A; Jacoby R; Jones R; Jones R; McKeith I; Macharouthu A; O'Brien J; Passmore P; Sheehan B; Juszczak E; Katona C; Hills R; Knapp M; Ballard C; Brown R; Banerjee S; Onions C; Griffin M; Adams J; Gray R; Johnson T; Bentham P; Phillips P N Engl J Med; 2012 Mar; 366(10):893-903. PubMed ID: 22397651 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy. Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434 [TBL] [Abstract][Full Text] [Related]
6. Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy. Modrego PJ; Fayed N; Errea JM; Rios C; Pina MA; Sarasa M Eur J Neurol; 2010 Mar; 17(3):405-12. PubMed ID: 19874395 [TBL] [Abstract][Full Text] [Related]
7. The Effect of Memantine on Cognitive Function and Behavioral and Psychological Symptoms in Mild-to-Moderate Alzheimer's Disease Patients. Zhang N; Wei C; Du H; Shi FD; Cheng Y Dement Geriatr Cogn Disord; 2015; 40(1-2):85-93. PubMed ID: 26066622 [TBL] [Abstract][Full Text] [Related]
8. [Multi-center open comparative randomized study of efficacy and safety of Akatinol Memantine 20 mg (single-doses) vs Akatinol Memantine 10 mg (double-doses) in patients with vascular dementia]. Gavrilova SI; Kolykhalov IV; Mikhaylova NM; Ponomareva EV; Fedorova YB; Medvedev VE; Frolova VI; Gushanskaya EV; Litvinenko IV; Emelin AY; Lobzin VY; Kashin AV; Tanashyan MM; Kachanova MV; Knyazev AV; Gonik MI Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):69-77. PubMed ID: 38465812 [TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease. Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693 [TBL] [Abstract][Full Text] [Related]
10. Effect of donepezil in patients with Alzheimer's disease previously untreated or treated with memantine or nootropic agents in Germany: an observational study. Klinger T; Ibach B; Schoenknecht P; Kamleiter M; Silver G; Schroeder J; Mielke R Curr Med Res Opin; 2005 May; 21(5):723-32. PubMed ID: 15969871 [TBL] [Abstract][Full Text] [Related]
11. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area. Araki T; Wake R; Miyaoka T; Kawakami K; Nagahama M; Furuya M; Limoa E; Liaury K; Hashioka S; Murotani K; Horiguchi J Int J Geriatr Psychiatry; 2014 Sep; 29(9):881-9. PubMed ID: 24436135 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study. Boada-Rovira M; Brodaty H; Cras P; Baloyannis S; Emre M; Zhang R; Bahra R; Drugs Aging; 2004; 21(1):43-53. PubMed ID: 14715043 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Raina P; Santaguida P; Ismaila A; Patterson C; Cowan D; Levine M; Booker L; Oremus M Ann Intern Med; 2008 Mar; 148(5):379-97. PubMed ID: 18316756 [TBL] [Abstract][Full Text] [Related]
14. Perspectives in the management of Alzheimer's disease: clinical profile of donepezil. Rogers SL Dement Geriatr Cogn Disord; 1998; 9 Suppl 3():29-42. PubMed ID: 9853200 [TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. Repantis D; Laisney O; Heuser I Pharmacol Res; 2010 Jun; 61(6):473-81. PubMed ID: 20193764 [TBL] [Abstract][Full Text] [Related]
16. Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. Porsteinsson AP; Grossberg GT; Mintzer J; Olin JT; Curr Alzheimer Res; 2008 Feb; 5(1):83-9. PubMed ID: 18288936 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial. Cumbo E; Ligori LD J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial. Jia J; Wei C; Jia L; Tang Y; Liang J; Zhou A; Li F; Shi L; Doody RS J Alzheimers Dis; 2017; 56(4):1495-1504. PubMed ID: 28157100 [TBL] [Abstract][Full Text] [Related]
19. DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. Jones R; Sheehan B; Phillips P; Juszczak E; Adams J; Baldwin A; Ballard C; Banerjee S; Barber B; Bentham P; Brown R; Burns A; Dening T; Findlay D; Gray R; Griffin M; Holmes C; Hughes A; Jacoby R; Johnson T; Jones R; Knapp M; Lindesay J; McKeith I; McShane R; Macharouthu A; O'Brien J; Onions C; Passmore P; Raftery J; Ritchie C; Howard R; Trials; 2009 Jul; 10():57. PubMed ID: 19630974 [TBL] [Abstract][Full Text] [Related]
20. Drugs for cognitive loss and dementia. Treat Guidel Med Lett; 2013 Oct; 11(134):95-100; quiz 1 p following p100.. PubMed ID: 24081314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]